Is Jon Springer’s UVE share grant a market purchase or compensation award?

The transaction is a compensation-related award, not a market purchase. It is coded as a grant or award acquisition, with 3,414 restricted shares received at a reported price of $0.00 per share under the company’s equity compensation arrangements.

Universal Insurance (NYSE: UVE) director receives 3,414 restricted shares award

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Springer Jon reported acquisition or exercise transactions in this Form 4 filing.

UNIVERSAL INSURANCE HOLDINGS, INC. director Jon Springer received a grant of 3,414 shares of common stock as equity compensation at no cash cost. Following this award, he directly holds 250,734 shares. These restricted shares vest on the earlier of June 11, 2027 or the next qualifying annual meeting.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Springer Jon

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,414	$0.00	--

Holdings After Transaction: Common Stock — 250,734 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Shares granted: 3,414 shares Award price: $0.00 per share Holdings after grant: 250,734 shares +1 more

4 metrics

Shares granted 3,414 shares Restricted common stock award to director Jon Springer

Award price $0.00 per share Equity compensation grant, non-cash

Holdings after grant 250,734 shares Total direct common stock holdings after transaction

Vesting date June 11, 2027 Latest possible vesting date for restricted shares

Key Terms

restricted shares, vest, annual meeting

3 terms

restricted shares financial

"These restricted shares will vest on the earlier of (i) June 11, 2027"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

vest financial

"These restricted shares will vest on the earlier of (i) June 11, 2027"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

annual meeting financial

"the date of the next annual meeting that is at least 50 weeks after"

A company's annual meeting is a yearly gathering where owners (shareholders) and the board review performance, ask questions, and vote on key matters like electing directors, approving auditor choices, and sometimes setting pay or dividend policies. For investors it matters because decisions made and votes cast can change who runs the company, influence strategy and payouts, and affect the value or direction of their investment—similar to a homeowners’ meeting where rules and leaders that shape your property’s value are decided.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/12/2026 - 05:02 PM Accepted by SEC EDGAR 06/12/2026 - 05:01 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Springer Jon

(Last)

(First)

(Middle)

1110 WEST COMMERCIAL BOULEVARD

SUITE 100

(Street)

FORT LAUDERDALE

FLORIDA

33309

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
UNIVERSAL INSURANCE HOLDINGS, INC. [ UVE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/11/2026		A		3,414⁽¹⁾	A	$0	250,734	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. These restricted shares will vest on the earlier of (i) June 11, 2027 and (ii) the date of the next annual meeting that is at least 50 weeks after the immediately preceding year's annual meeting.

Remarks:

	/s/ Jon Springer	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did UVE director Jon Springer report?

Jon Springer reported receiving a grant of 3,414 shares of Universal Insurance Holdings common stock. The shares were awarded at no cash cost as equity compensation and increase his direct holdings to 250,734 shares following the transaction.

At what price were Jon Springer’s new UVE shares acquired?

The 3,414 shares were acquired at a reported price of $0.00 per share. This indicates an equity compensation award rather than an open-market purchase, providing additional stock-based incentives without an out-of-pocket cash payment.

When do Jon Springer’s new UVE restricted shares vest?

The restricted shares vest on the earlier of June 11, 2027 or the date of the next annual meeting that is at least 50 weeks after the prior year’s annual meeting, tying vesting to both time and a future shareholder meeting.

How many UVE shares does Jon Springer hold after this Form 4?

After the reported grant, Jon Springer directly holds 250,734 shares of Universal Insurance Holdings common stock. This total includes the 3,414 newly awarded restricted shares that are subject to vesting based on time and the timing of a future annual meeting.